Biochemistry

A new research center at the University of Illinois Urbana-Champaign will create whole-cell models that promise to transform our understanding of how cells function. With cutting-edge imaging and simulation tools, the center will advance the study of healthy and diseased cells; accelerate research...

CAR-T immune therapies could be effective against solid tumors if the right targets are identified, a new study led by University of Illinois Urbana-Champaign researchers suggests. The researchers successfully deployed CAR-T in a mouse model of ovarian cancer, a type of aggressive, solid-tumor...

Scientists have identified a protein that plays a pivotal role in the action of several emerging cancer therapies. The researchers say the discovery will likely aid efforts to fine-tune the use of immunotherapies against several challenging cancers.

With great sadness, the Department of Biochemistry and School of Molecular & Cellular Biology announce the passing of professor Emeritus H. Edward Conrad, 94, on May 23, 2023, in Urbana.

Twelve students have been selected to receive 2023 Beckman Institute fellowships and awards. The awards, which fund interdisciplinary research that takes place over the summer, will be celebrated at a poster session on July 28, 2023.

The Beckman Institute has announced its 2023 class of six postdoctoral fellows. Fellows are selected in accordance with the core values of the institute: excellence, collaboration, integrity, transdisciplinarity, exploration, and diversity.

The University of Illinois Urbana-Champaign has been chosen to lead the Chan Zuckerberg Biohub Chicago – a new biomedical hub – along with the University of Chicago and Northwestern University. The three-university team was selected to lead the new biomedical hub as part of a competitive...

Researchers have discovered the addition of fluid to human pathogens triggers a "windchill-like" effect that sensitizes cells to hydrogen peroxide, a well-known agent of cell stress and DNA damage. Their findings have been published in PNAS.

The SRSF1 gene acts as a guardian against DNA damage in the liver, School of MCB researchers found. When it is missing or inactivated, severe nonalcoholic fatty liver disease symptoms develop.